Skip to main content
Premium Trial:

Request an Annual Quote

Bacterial Genomics Firm Era7 Bioinformatics Receives $400K Investment

NEW YORK (GenomeWeb) – Era7 Bioinformatics today announced a $400,000 investment in the firm by Comercial Rafer to help accelerate the international expansion of the company.

Era7, which is based in Spain, said that it specifically wants to expand its operations in the US, where it has a subsidiary headquartered in Cambridge, Mass. It and Comercial Rafer have also reached a distribution agreement for Era7's services covering Spain and Portugal, Era7 CEO Eduardo Pareja said in a statement.

Era7 provides services focused on next-generation sequencing and bioinformatics for bacterial genomics and metagenomics. Comercial Rafer, also based in Spain, helps clinical and industrial R&D firms commercialize reagents and instruments.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.